Bite sized info on HLUN: patent...now protects the worldwide rights for the Company's method for producing collagen producing cells from adult stem cells via transfection. This proprietary technology marks the next step toward the Company becoming the first to commercialize non-embryonic stem cell use in the $15 billion worldwide plastic surgery and cosmetic surgery market.
The above was in pr Jan 3, 2007
Set your desire to Eternal Riches, the true riches.